Cingulate announces warrant exercise for $1.86M gross proceeds; new Series C/D warrants issued

Cingulate Inc.

Immediate cash exercise of Series A (2.125M shares) and Series B (1.0625M shares) warrants at reduced price $0.585/share (was $2.00).
Gross proceeds ~$1.86M; proceeds for CTx-1301 development, working capital, and general corporate purposes.
Company issues new Series C warrants (4.25M shares) and Series D warrants (2.125M shares) at $0.585/share, exercisable after stockholder approval.
H.C. Wainwright as placement agent; receives 8% cash fee and placement agent warrants for 255,000 shares at $0.7313/share.
Stockholder meeting required within 90 days to approve new warrant exercises per Nasdaq Listing Rule 5635.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.